In general, the aim of the present study is to investigate whether AS-IV ameliorates DN via the regulation of eNOS in vivo using DN-induced rats model, while the renal protection activities of AS-IV in high glucose (HG)-induced HRGECs were further investigated in vitro. The gene discussed is NOS3; the disease is liver dysplastic nodule.